ArticlePloS one2018

HL156A, a novel pharmacological agent with potent adenosine-monophosphate-activated protein kinase (AMPK) activator activity ameliorates renal fibrosis in a rat unilateral ureteral obstruction model.

Bodokhsuren Tsogbadrakh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.